Cytosorbents

$9.21
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.46 (+5.26%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Cytosorbents and other stocks, options, and ETFs commission-free!

About CTSO

CytoSorbents Corp. engages in the critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio include CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ. The listed name for CTSO is Cytosorbents Corporation Common Stock.

CEO

Phillip P. Chan

Employees

153

Headquarters

Monmouth Junction, New Jersey

Founded

2002

Market Cap

397.65M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

458.53K

High Today

$9.25

Low Today

$8.65

Open Price

$8.73

Volume

412.81K

52 Week High

$11.74

52 Week Low

$3.60

Collections

Technology

Health

Medical

Research And Development

North America

Analyst Ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

CTSO Earnings

-$0.22

-$0.15

-$0.07

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 2, After Hours